Is Kerala remaining low prevalent in human immunodeficiency virus by accident? a study of risk factors in acquiring human immunodeficiency virus infection in patients attending Anti-retroviral treatment clinic
Kidangazhiayathmana, A.
Indian Journal of Dermatology Venereology and Leprology 77(6): 729
2011
ISSN/ISBN: 0973-3922 PMID: 22016292 DOI: 10.4103/0378-6323.86503Document Number: 561094
Document emailed within 0-6 h
Related Documents
Kline, M.W.; Lewis, D.E.; Hollinger, F.B.; Reuben, J.M.; Hanson, L.C.; Kozinetz, C.A.; Dimitrov, D.H.; Rosenblatt, H.M.; Shearer, W.T. 1994: A comparative study of human immunodeficiency virus culture, polymerase chain reaction and anti-human immunodeficiency virus immunoglobulin A antibody detection in the diagnosis during early infancy of vertically acquired human immunodeficiency virus infection Pediatric Infectious Disease Journal 13(2): 90-94Paranthaman, K.; Kumarasamy, N.; Bella, D.; Webster, P. 2009: Factors influencing adherence to anti-retroviral treatment in children with human immunodeficiency virus in South India--a qualitative study Aids Care 21(8): 1025-1031
Evans, B.A.; Mccormack, S.M.; Bond, R.A.; Macrae, K.D.; Thorp, R.W. 1988: Human immunodeficiency virus infection, hepatitis B virus infection, and sexual behaviour of women attending a genitourinary medicine clinic British Medical Journal 296(6620): 473-475
Koyanagi, A.; Humphrey, J.H.; Ntozini, R.; Nathoo, K.; Moulton, L.H.; Iliff, P.; Mutasa, K.; Ruff, A.; Ward, B.; Chidawanyika, H.; Hargrove, J.; Mahomva, A.I.; Majo, F.; Malaba, L.C.; Mbizvo, M.T.; Mzengeza, F.; Ndhlovu, M.; Piwoz, E.; Propper, L.; Rambanepasi, P.; Ruff, A.J.; Tavengwa, N.; Zijenah, L.S.; Zunguza, C.D.; Zvandasara, P. 2011: Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy Pediatric Infectious Disease Journal 30(1): 45-51
Diaz, A.; Ten, A.; Marcos, H.; Gutiérrez, G.; González-García, J.; Moreno, S.; Barrios, A.M.ía.; Arponen, S.; Portillo, Ál.; Serrano, R.; García, M.T.; Pérez, J.é L.; Toledo, J.; Royo, M.C.; González, G.; Izquierdo, A.; Viloria, L.J.; López, I.; Elizalde, L.áz.; Martínez, E.; Castrillejo, D.; Aranguren, R.; Redondo, C.; Diez, M. 2015: Factors determining irregular attendance to follow-up visits among human immunodeficiency virus patients: results of the hospital survey of patients infected with human immunodeficiency virus Enfermedades Infecciosas y Microbiologia Clinica 33(5): 324-330
Plourde, P.J.; Plummer, F.A.; Pepin, J.; Agoki, E.; Moss, G.; Ombette, J.; Ronald, A.R.; Cheang, M.; D'Costa, L.; Ndinya-Achola, J.O. 1992: Human immunodeficiency virus type 1 infection in women attending a sexually transmitted diseases clinic in Kenya Journal of Infectious Diseases 166(1): 86-92
Nguyen, P.A.; Syed-Abdul, S.; Minamareddy, P.; Lee, P.; Ngo, T.D.; Iqbal, U.; Nguyen, P.H.; Jian, W.-S.; Li, Y.-C.J. 2013: A method to manage and share anti-retroviral (ARV) therapy information of human immunodeficiency virus (HIV) patients in Vietnam Computer Methods and Programs in Biomedicine 111(2): 290-299
Sabidó, M.; Lahuerta, M.; Montoliu, A.; Gonzalez, V.; Hernández, G.; Giardina, F.; Monzón, J.é E.; Pedroza, M.I.; Casabona, J. 2011: Human immunodeficiency virus, sexually transmitted infections, and risk behaviors among clients of sex workers in Guatemala: are they a bridge in human immunodeficiency virus transmission? Sexually Transmitted Diseases 38(8): 735-742
Anonymous 1988: 1988 agent summary statement for human immunodeficiency virus and report on laboratory-acquired infection with human immunodeficiency virus Morbidity and Mortality Weekly Report 37(S-4): 22
Maurer, T.A.; Christian, K.V.; Kerschmann, R.L.; Berzin, B.; Palefsky, J.M.; Payne, D.; Tyring, S.K.; Berger, T.G. 1997: Cutaneous squamous cell carcinoma in human immunodeficiency virus-infected patients. A study of epidemiologic risk factors, human papillomavirus, and p53 expression Archives of Dermatology 133(5): 577-583
Ruzibakiev, R.; Kato, H.; Ueda, R.; Yuldasheva, N.; Hegay, T.; Avazova, D.; Kurbanov, F.; Zalalieva, M.; Tuichiev, L.; Achundjanov, B.; Mizokami, M. 2001: Risk factors and seroprevalence of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection in uzbekistan Intervirology 44(6): 327-332
Diendéré, E.A.; Tiéno, H.; Bognounou, R.; Ouédraogo, D.D.; Simporé, J.; Ouédraogo-Traoré, R.; Drabo, J. 2011: Prevalence and risk factors associated with infection by human immunodeficiency virus, hepatitis B virus, syphilis and bacillary pulmonary tuberculosis in prisons in Burkina Faso Medecine Tropicale: Revue du Corps de Sante Colonial 71(5): 464-467
Maity, S.; Nandi, S.; Biswas, S.; Saha, M.K. 2012: Human immunodeficiency virus seroprevalence among patients attending a sexually transmitted disease clinic in West Bengal, India Japanese Journal of Infectious Diseases 65(5): 424-426
Wen, Y.; Guan, J.; Wu, Z.; Li, L.; Rotheram-Borus, M.Jane.; Lin, C.; Detels, R. 2009: Pharmacy workers' sexually transmitted diseases/human immunodeficiency virus knowledge in Fuzhou, China: implications for human immunodeficiency virus testing, treatment, and prevention strategies Sexually Transmitted Diseases 36(4): 221-226
Moy, F.S.; Fahey, P.; Nik Yusoff, N.K.; Razali, K.A.; Nallusamy, R. 2015: Outcomes of human immunodeficiency virus-infected children after anti-retroviral therapy in Malaysia Journal of Paediatrics and Child Health 51(2): 204-208
Segat, L.; Crovella, S. 2012: HLA-G 14bp del/ins genetic variation: association with susceptibility to human immunodeficiency virus-1 vertical transmission but not with human immunodeficiency virus-1 infection through horizontal transmission Tissue Antigens 80(1): 12-13
Hernández Aguado, I.; Fernández García, E.; García de la Hera, M.; Alvarez-Dardet, C. 1992: Infection caused by the human immunodeficiency virus type 1 in prostitutes and risk factors Medicina Clinica 99(11): 406-409
Lin, W.-C.; Lin, H.-H.; Lee, S.S.-J.; Sy, C.-L.; Wu, K.-S.; Chen, J.-K.; Tsai, H.-C.; Chen, Y.-S. 2016: Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country Journal of Microbiology Immunology and Infection 49(5): 729-736
Sungkanuparph, S.; Vibhagool, A.; Manosuthi, W.; Kiertiburanakul, S.; Atamasirikul, K.; Aumkhyan, A.; Thakkinstian, A. 2004: Prevalence of hepatitis B virus and hepatitis C virus co-infection with human immunodeficiency virus in Thai patients: a tertiary-care-based study Journal of the Medical Association of Thailand 87(11): 1349-1354
Wang, J.; Liu, J.; Huang, Y.; Yang, T.; Yao, F.; Dong, X.; Wen, G.; Bi, X.; Zhao, M.; Wen, X.; Huang, M.; Lü, Y.; Ma, H.; Yu, Q.; Wright, D.; Guo, N.; Ness, P.; Shan, H. 2013: An analysis of risk factors for human immunodeficiency virus infection among Chinese blood donors Transfusion 53(10 Pt 2): 2431-2440